Adam J. DiPippo - Search Results

Year	Number of Results
2016	2
2017	1
2018	3
2019	6
2020	4
2021	4
2022	1
2023	2
2024	0

1

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.

Rausch CR, DiNardo CD, Maiti A, Jammal NJ, Kadia TM, Marx KR, Borthakur G, Savoy JM, Pemmaraju N, DiPippo AJ, Daver NG, Chew SM, Sasaki K, Issa GC, Short NJ, Takahashi K, Ohanian MN, Ning J, Xiao L, Alvarado Y, Kontoyiannis DP, Ravandi F, Kantarjian HM, Konopleva MY. Rausch CR, et al. Among authors: dipippo aj. Cancer. 2021 Jul 15;127(14):2489-2499. doi: 10.1002/cncr.33508. Epub 2021 Apr 1. Cancer. 2021. PMID: 33793970 Free PMC article.

2

Targeting CD123 in BPDCN: an emerging field.

DiPippo AJ, Wilson NR, Pemmaraju N. DiPippo AJ, et al. Expert Rev Hematol. 2021 Nov;14(11):993-1004. doi: 10.1080/17474086.2021.1988848. Epub 2021 Oct 29. Expert Rev Hematol. 2021. PMID: 34607517 Review.

3

Reply to Cheng and Chuang.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP. Avery LM, et al. Among authors: dipippo aj. Clin Infect Dis. 2019 Aug 16;69(5):903-904. doi: 10.1093/cid/ciz081. Clin Infect Dis. 2019. PMID: 30715199 No abstract available.

4

Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemia.

Paul S, DiPippo AJ, Ravandi F, Kadia TM. Paul S, et al. Among authors: dipippo aj. Future Oncol. 2019 Dec;15(34):3885-3894. doi: 10.2217/fon-2019-0353. Epub 2019 Sep 27. Future Oncol. 2019. PMID: 31559849 Review.

5

Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations.

Buege MJ, DiPippo AJ, DiNardo CD. Buege MJ, et al. Among authors: dipippo aj. Cancers (Basel). 2018 Jun 6;10(6):187. doi: 10.3390/cancers10060187. Cancers (Basel). 2018. PMID: 29882807 Free PMC article. Review.

6

Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.

Rausch CR, DiPippo AJ, Jiang Y, DiNardo CD, Kadia T, Maiti A, Montalban-Bravo G, Ravandi F, Kontoyiannis DP. Rausch CR, et al. Among authors: dipippo aj. Clin Infect Dis. 2022 Oct 29;75(9):1503-1510. doi: 10.1093/cid/ciac230. Clin Infect Dis. 2022. PMID: 35325094

7

Non-Aspergillus invasive mould infections in patients treated with ibrutinib.

Anastasopoulou A, DiPippo AJ, Kontoyiannis DP. Anastasopoulou A, et al. Among authors: dipippo aj. Mycoses. 2020 Aug;63(8):787-793. doi: 10.1111/myc.13120. Epub 2020 Jun 19. Mycoses. 2020. PMID: 32458510 Review.

8

Azole-Associated Pseudohyperaldosteronism: A Class Effect or Azole-Specific?

Dipippo AJ, Kontoyiannis DP. Dipippo AJ, et al. Clin Infect Dis. 2020 Jul 11;71(2):467-468. doi: 10.1093/cid/ciz944. Clin Infect Dis. 2020. PMID: 31674639 No abstract available.

9

Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future.

DiPippo AJ, Patel NK, Barnett CM. DiPippo AJ, et al. Pharmacotherapy. 2016 Jun;36(6):652-67. doi: 10.1002/phar.1756. Epub 2016 May 28. Pharmacotherapy. 2016. PMID: 27087139 Review.

10

Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center.

McGhie A, Lee J, Ferrajoli A, DiPippo AJ. McGhie A, et al. Among authors: dipippo aj. Leuk Lymphoma. 2023 May;64(5):1050-1053. doi: 10.1080/10428194.2023.2185089. Epub 2023 Mar 8. Leuk Lymphoma. 2023. PMID: 36891585 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year